BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8118449)

  • 1. Retraction of cultured endothelial cell monolayer by human breast cancer cells, MCF-7.
    Yoshioka K; Mukai M; Shinkai K; Akedo H
    Cell Biol Int; 1993 Dec; 17(12):1053-63. PubMed ID: 8118449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM; Murthy L; Stancel GM
    Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
    Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Werner HM; Franke HR; Vermes I
    Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interaction between estradiol-17 beta and progesterone on the proliferation of cloned breast tumor cells (MCF-7 and T47D).
    Schatz RW; Soto AM; Sonnenschein C
    J Cell Physiol; 1985 Sep; 124(3):386-90. PubMed ID: 4044660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid.
    Martin TA; Das T; Mansel RE; Jiang WG
    J Cell Biochem; 2007 May; 101(1):155-66. PubMed ID: 17243118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells.
    Narita T; Kawakami-Kimura N; Matsuura N; Hosono J; Kannagi R
    Anticancer Res; 1995; 15(6B):2523-7. PubMed ID: 8669817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial injury causes degradation of adjacent basement membranes and promotes their invasion by A549 carcinoma cells.
    Missirlis E; Whaley M; Lhotak S; Orr FW
    Invasion Metastasis; 1992; 12(1):35-46. PubMed ID: 1512135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
    Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
    Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
    Honn KV; Tang DG; Grossi I; Duniec ZM; Timar J; Renaud C; Leithauser M; Blair I; Johnson CR; Diglio CA
    Cancer Res; 1994 Jan; 54(2):565-74. PubMed ID: 8275495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cells cause vascular endothelial cell (vEC) retraction via 12(S)HETE secretion; the possible role of cancer cell derived microparticle.
    Uchide K; Sakon M; Ariyoshi H; Nakamori S; Tokunaga M; Monden M
    Ann Surg Oncol; 2007 Feb; 14(2):862-8. PubMed ID: 17103063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell contact causes oscillatory and polarized rise of cytoplasmic ionized calcium concentration in human umbilical vein endothelial cells.
    Tsuji Y; Nakamori S; Ariyoshi H; Sakon M; Aono Y; Ueda A; Tokunaga M; Nakamura T; Monden M
    Int J Oncol; 2002 Sep; 21(3):541-6. PubMed ID: 12168097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.